Related Experiment Video
Updated: Jan 14, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Obesity due to MC4R deficiency is associated with reduced cholesterol, triglycerides and cardiovascular disease risk
Stefanie Zorn1,2, Rebecca Bounds1, Alice Williamson3,4
1University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Abstract:
Obesity causes dyslipidemia and is a major risk factor for cardiovascular disease. However, the mechanisms coupling weight gain and lipid metabolism are poorly understood. Brain melanocortin 4 receptors (MC4Rs) regulate body weight and lipid metabolism in mice, but the relevance of these findings to humans is unclear. Here we investigated lipid levels in men and women with obesity due to MC4R deficiency. Among 7,719 people from the Genetics of Obesity Study cohort, we identified 316 probands and 144 adult family members with loss-of-function (LoF) MC4R mutations. Adults with MC4R deficiency had lower levels of total and low-density lipoprotein (LDL)-cholesterol and triglycerides than 336,728 controls from the UK Biobank, after adjusting for adiposity. Carriers of LoF MC4R variants within the UK Biobank had lower lipid levels and a lower risk of cardiovascular disease, after accounting for body weight, compared to noncarriers. After a high-fat meal, the postprandial rise in triglyceride-rich lipoproteins and metabolomic markers of fatty acid oxidation were reduced in people with MC4R deficiency compared to controls, changes that favor triglyceride storage in adipose tissue. We concluded that central MC4Rs regulate lipid metabolism and cardiovascular disease risk in humans, highlighting potential therapeutic approaches for cardiovascular risk reduction.
Insights
Deficiency in brain melanocortin 4 receptors (MC4Rs) lowers cholesterol and triglycerides in humans, reducing cardiovascular disease risk. This suggests MC4Rs are key regulators of lipid metabolism and heart health.
Area of Science:
- Endocrinology
- Metabolic Syndrome
- Cardiovascular Science
Background:
- Obesity is linked to dyslipidemia and cardiovascular disease, but the underlying mechanisms are unclear.
- Brain melanocortin 4 receptors (MC4Rs) influence weight and lipid metabolism in animal models, but human relevance is uncertain.
- Understanding MC4R's role in human lipid metabolism is crucial for cardiovascular disease prevention.
Purpose of the Study:
- To investigate the impact of melanocortin 4 receptor (MC4R) deficiency on lipid levels and cardiovascular disease risk in humans.
- To determine if MC4R loss-of-function variants are associated with altered lipid profiles and cardiovascular outcomes.
Main Methods:
- Analysis of lipid levels in individuals with obesity due to MC4R deficiency (n=460) compared to UK Biobank controls (n=336,728).
- Assessment of lipid profiles and cardiovascular disease risk in carriers of MC4R loss-of-function variants within the UK Biobank.
- Evaluation of postprandial lipemia and metabolomic markers after a high-fat meal in individuals with MC4R deficiency versus controls.
Main Results:
- Adults with MC4R deficiency exhibited lower total cholesterol, LDL-cholesterol, and triglyceride levels compared to controls, independent of adiposity.
- MC4R variant carriers showed reduced lipid levels and a lower risk of cardiovascular disease, even after adjusting for body weight.
- Individuals with MC4R deficiency displayed a blunted postprandial triglyceride response and altered fatty acid oxidation markers, favoring fat storage.
Conclusions:
- Central MC4Rs play a significant role in regulating human lipid metabolism.
- MC4R deficiency is associated with improved lipid profiles and reduced cardiovascular disease risk.
- Targeting MC4Rs presents a potential therapeutic strategy for managing dyslipidemia and cardiovascular risk.
Related Concept Videos
Obesity
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures

